NCT06543602 · RECRUITING

the Multi-modal Evaluation of Agitation in Critically Ill Patients Based on Remote Video-Ultra-sensitive Detection Wave

This observational study is testing a monitoring system that uses remote video and ultra-sensitive motion-detection technology to identify agitation in critically ill ICU patients. Researchers want to know how well this multi-modal system works compared to standard assessment methods. There is no assigned phase listed, and no drug or therapy is being given — this is purely a diagnostic and monitoring technology study conducted over three years.

You may qualify if

  • Patients at risk of agitation in the ICU
  • Patients with RASS score -2 and above
  • ≦ 65 years old, ≧ 18 years old

You're excluded if

  • The affected party refused to participate in this study
  • Missing/incomplete information
  • Vulnerable groups such as pregnant women, those who lack the capacity for civil conduct and do not have the consent of their legal representatives
  • Maxillofacial trauma, burns, tumors, surgery, etc. affect facial expression
  • Patients with limb impairment and amputation
  • Spinal cord injury, limb movement/sensory limitations
  • Patients with pre-existing neurological/psychiatric diseases
  • Patients with malignant tumors
  • Patients with infectious diseases
  • Patients with terminal disease and dying disease
  • Abnormal behavior due to head injury or craniocerebral disease

The sponsor's own eligibility wording, lightly reformatted. The study team makes the final eligibility decision — worth discussing with your doctor.

Eligibility criteria as of 2024-08-09

View full record on ClinicalTrials.gov

All APOE4 clinical trials